163 related articles for article (PubMed ID: 25826018)
1. De novo produced anti-human leukocyte antigen antibodies relation to alloimmunity in patients with chronic renal failure.
Pirim I; Soyoz M; Ayna TK; Kocyigit AO; Gurbuz BC; Tugmen C; Kurtulmus Y; Ozyilmaz B
Genet Test Mol Biomarkers; 2015 Jun; 19(6):335-8. PubMed ID: 25826018
[TBL] [Abstract][Full Text] [Related]
2. Effects of different sensitization events on HLA alloimmunization in solid organ transplantation patients.
Hyun J; Park KD; Yoo Y; Lee B; Han BY; Song EY; Park MH
Transplant Proc; 2012 Jan; 44(1):222-5. PubMed ID: 22310619
[TBL] [Abstract][Full Text] [Related]
3. Association Between HLA Antibodies and Different Sensitization Events in Renal Transplant Candidates.
Akgul SU; Ciftci HS; Temurhan S; Caliskan Y; Bayraktar A; Tefik T; Kaya IA; Canitez IO; Demir E; Yazici H; Bakkaloglu H; Aydin AE; Turkmen A; Nane I; Aydin F; Oguz FS
Transplant Proc; 2017 Apr; 49(3):425-429. PubMed ID: 28340805
[TBL] [Abstract][Full Text] [Related]
4. Effect of Single Sensitization Event on Human Leukocyte Antigen Alloimmunization in Kidney Transplant Candidates: A Single-Center Experience.
Resse M; Paolillo R; Pellegrino Minucci B; Costa D; Fiorito C; Santangelo M; De Rosa P; Napoli C
Exp Clin Transplant; 2018 Feb; 16(1):44-49. PubMed ID: 28661314
[TBL] [Abstract][Full Text] [Related]
5. Risk factors of sensitization to human leukocyte antigen in end-stage renal disease patients.
Hung SY; Lin TM; Chang MY; Wang HH; Lee YC; Ho LC; Chen YT; Hung CM; Liou HH
Hum Immunol; 2014 Jun; 75(6):531-5. PubMed ID: 24607727
[TBL] [Abstract][Full Text] [Related]
6. Effects of different sensitization events on HLA alloimmunization in renal transplant cases; a retrospective observation in 1066 cases.
Pandey P; Pande A; Mandal S; Devra AK; Sinha VK; Bhatt AP; Mishra S
Transpl Immunol; 2022 Dec; 75():101680. PubMed ID: 35908630
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive assessment of sensitizing events and anti-HLA antibody development in women awaiting kidney transplantation.
Picascia A; Grimaldi V; Sabia C; Napoli C
Transpl Immunol; 2016 May; 36():14-9. PubMed ID: 27013139
[TBL] [Abstract][Full Text] [Related]
8. Association of HLA phenotypes of end-stage renal disease patients preparing for first transplantation with anti-HLA antibody status.
Karahan GE; Kekik C; Oguz FS; Onal AE; Bakkaloğlu H; Calişkan YK; Yazici H; Turkmen A; Aydin AE; Sever MS; Eldegez U; Carin MN
Ren Fail; 2010 Jan; 32(3):380-3. PubMed ID: 20370456
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric evaluation of pregnancy-induced anti-donor immunization.
Ayna TK; Ciftci HS; Tozkir H; Sagiroglu T; Isitmangil G; Gurtekin B; Gurtekin M
Transplant Proc; 2012; 44(6):1656-9. PubMed ID: 22841238
[TBL] [Abstract][Full Text] [Related]
10. DETERMINATION OF THE PRA POSITIVITY PERCENTAGE IN MALE PATIENTS WITH CHRONIC KIDNEY DISEASE BY USING FLOW CYTOMETRY TECHNIQUE.
Merdin FA; Koçak H; Köksoy S
Acta Clin Croat; 2023 Aug; 62(2):262-269. PubMed ID: 38549598
[TBL] [Abstract][Full Text] [Related]
11. Successful unintentional ABO-incompatible renal transplantation: Blood group A1B donor into an A2B recipient.
Fadeyi EA; Stratta RJ; Farney AC; Pomper GJ
Am J Clin Pathol; 2014 May; 141(5):724-6. PubMed ID: 24713746
[TBL] [Abstract][Full Text] [Related]
12. Anti-HLA antibody profile of Turkish patients with end-stage renal disease.
Karahan GE; Seyhun Y; Oguz F; Kekik C; Onal E; Caliskan Y; Bakkaloglu H; Yazici H; Turkmen A; Aydin AE; Sever MS; Eldegez U; Carin MN
Transplant Proc; 2009 Nov; 41(9):3651-4. PubMed ID: 19917361
[TBL] [Abstract][Full Text] [Related]
13. Significance of panel reactive antibodies in patients requiring kidney transplantation.
Mishra MN; Baliga KV
Saudi J Kidney Dis Transpl; 2013 May; 24(3):495-9. PubMed ID: 23640620
[TBL] [Abstract][Full Text] [Related]
14. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
15. [Anti-HLA antibodies after bone graft and their impact on kidney transplant programs].
Mosconi G; Baraldi O; Fantinati C; Cappuccilli ML; Corsini S; Zanelli P; Bassi A; Buscaroli B; Feliciangeli G; Stefoni S
G Ital Nefrol; 2009; 26 Suppl 45():S58-63. PubMed ID: 19382096
[TBL] [Abstract][Full Text] [Related]
16. Red blood cell transfusions and the risk of allosensitization in patients awaiting primary kidney transplantation.
Leffell MS; Kim D; Vega RM; Zachary AA; Petersen J; Hart JM; Rossert J; Bradbury BD
Transplantation; 2014 Mar; 97(5):525-33. PubMed ID: 24300013
[TBL] [Abstract][Full Text] [Related]
17. Harmful effect of preformed anti-MICA antibodies on renal allograft evolution in early posttransplantation period.
Sánchez-Zapardiel E; Castro-Panete MJ; Castillo-Rama M; Morales P; Lora-Pablos D; Valero-Hervás D; Ruiz-García R; Apaza J; Talayero P; Andrés A; Morales JM; Paz-Artal E
Transplantation; 2013 Jul; 96(1):70-8. PubMed ID: 23624543
[TBL] [Abstract][Full Text] [Related]
18. Potential risk factors for hypersensitization reflected by panel-reactive antibodies in dialysis patients.
Pour-Reza-Gholi F; Daneshvar S; Nafar M; Firouzan A; Farrokhi F; Einollahi B
Transplant Proc; 2005 Sep; 37(7):2936-8. PubMed ID: 16213266
[TBL] [Abstract][Full Text] [Related]
19. [Immunologic and transplantation biology studies in patients with terminal renal failure].
Lanzer G
Wien Med Wochenschr Suppl; 1985; 89():1-48. PubMed ID: 3892933
[TBL] [Abstract][Full Text] [Related]
20. De novo donor-specific human leukocyte antigen antibodies early after kidney transplantation.
Heilman RL; Nijim A; Desmarteau YM; Khamash H; Pando MJ; Smith ML; Chakkera HA; Huskey J; Valdez R; Reddy KS
Transplantation; 2014 Dec; 98(12):1310-5. PubMed ID: 24879384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
